Conference Agenda

09:00

Registration & Refreshment

09:30

Inaugural Ceremony
Speakers
Komal Kalha,
Senior Counsel
US Patent and Trademark Office
USA

10:15

Five years of Inter Partes Review : Effectiveness and Expectations
Speakers
Tedd Van Buskirk,
Partner
Lerner David

10:50

BREAK

11:15

ANDA filing and litigation : Strategies to Respond
Panelists
Steve Coyle,
Partner
Cantor Colburn LLP

11:50

Update for Para IV Litigation: Latest Developments in the Federal Courts and PTAB
Speakers
Sailesh K. Patel,
Partner
Schiff Hardin LLP

12:30

Solving The Roadblocks : Increasing efficiency while limiting the US Litigation Costs
Speakers
Shashank Upadhye,
Partner
Amin Talati Upadhye

01:10

LUNCH

02:00

Pushing the boundaries of Hatch-Waxman defences: obviousness and inherency

02:40

Induced Infringement: Product Labeling and the Implications of the Federal Circuit’s Decision in Sanofi v. Watson
Speaker: Ronald M. Daignault

03:15

Risk Evaluation and Mitigation Strategies (REMS): Update
Speakers
Stephen R Auten,
Partner
Taft Stettinius & Hollister LLP

03:50

Refreshments and Networking

04:15

Patent framework for amplified Biosimilars space : Detailed understanding

04:50

Latest Developments in the Federal Courts and PTAB
Speakers
Christopher Griffith,
Partner
Green, Griffith & Borg-Breen LLP

05:30

Interactive Discussion: REINVENTING THE WHEEL THROUGH SUPER GENERICS WITH 505(b)(2)
Speakers
Bharati Nadkarni,
Vice President
Sun Pharma
Dr. Alpesh Pathak,
Global IP Head
Intas Pharmaceuticals Ltd.
Seema Singh,
Associate Director
Abbott
Taranpreet Singh Lamba,
Vice President of Intellectual Property and Product Portfolio Management
Glenmark Pharmaceuticals Limited
Arshad Jamil,
Head IP
Biocon

06:30

Closing remarks from the Chair

06:40

Cocktail Opening Remarks

09:00

Registration

09:30

Opening Remarks by the CHAIR
Europe

09:40

Understanding the Unitary Patent System
Unitary Patent system (No 1257/2012 and No 1260/2012) entered into force on 20 January 2013 and will be operational during the course of 2018.
Speakers
Dr. Dieter Tzschoppe,
Director Operations Biotechnology / Pure and Applied organic Chemistry | Dir. 1.4
European Patent Office

10:20

Patent Term Extension and Supplementary Protection Certificate regime
Speakers
Ravi Srinivasan,
Partner
Patent Attorney, J A Kemp

11:00

Break

11:30

Patent Litigation in Europe: Change is Coming
Speakers
Andy Camenisch,
Partner
HGF Ltd.

12:30

Implications of IP enforcement on trademarks on Indian exports

12:50

Precious biosimilars are kicking off – the present situation in the EU
Speakers
Dr. Alexander Wittkopp,
Patentanwälte PartmbB Hamm&Wittkopp
Europe

01:30

LUNCH
SOUTH AFRICA

02:30

Patent system and litigation strategies in South Africa
MIDDLE EAST

03:10

Understanding the Middle Eastern patent landscape
AUSTRALIA / NEW ZEALAND  

03:50

Patent protection in Australia & New Zealand and Opening the way for biosimilar versions
Speakers
Wayne Condon,
 
Griffith Hack

04:30

Break

05:00

Fireside Chat: An in-depth chat with MD / CEO of a leading pharmaceutical company to understand how patents impact business in pharma sector.

06:30

Closing Remarks by the CHAIR

06:45

Cocktail Opening Remarks

09:00

Registration

09:30

Recap and remarks by the CHAIR
India

09:45

Keynote Address
Speakers
OP Gupta (IAS),
Controller General of Patents, Designs & Trade Marks, DiPP
Ministry of Commerce and Industry, Government of India

10:20

IPR Strategy in India
Speakers
Saya Choudhary Kapur,
Partner
Singh & Singh Lall & Sethi

11:15

PANEL DISCUSSION:
Patents Vs. Early Market Entry of Indian Generics
Speakers
Dr. Paras R Vasanani,
Assistant General Manager – Global Intellectual Property Department
Amneal Pharmaceuticals Pvt Ltd.
Srikanta Patra,
Pellets Pharma
Head, Global IP & Strategic Planning
Swati Veera,
Senior In-House Patent Attorney
Indoco Remedies Limited
Alka Mehta,
Head Formulations IP
Lupin Ltd

12:15

BREAK

12:30

Addressing Compulsory Licensing Issue
Speakers
Richa Pandey,
Patent Attorney & Partner
Krishna and Saurastri Associates

01:00

Role of Information Governance for Cost effective eDiscovery
01
Speakers
Sanjay Kumar,
Former Head - Legal, Ethics and Compliance
GSKConsumer ( JV of GSK & Novartis)

01:15

Managing IP while Adopting Innovative Pharma Marketing strategy with Social Media SYNOPSIS:
Speakers
Sanjay Kumar,
Former Head - Legal, Ethics and Compliance
GSKConsumer ( JV of GSK & Novartis)

01:30

LUNCH
Japan

02:30

The Long Road : Meeting Japanese IP Standards
Speakers
Yoshiyuki OSABE,
Deputy Director
Patent Information Policy Planning Division, Japan Patent Office.
China

03:10

Paving the way for

03:30

World Café : Join together in smaller groups with your industry colleagues and debate over latest patent cases hitting the newspaper headlines across the globe
Brazil / Mexico    

04:00

Amendments in patent law and recent patent infringement case laws
SOUTH ASIAN REGIONS  

04:15

Opportunities for India in Indonesian Pharmaceutical Market

04:45

Closing Remarks by the CHAIR

05:00

End of the conference